Predictive Value of Lactate/Albumin Ratio for Death and Multiple Organ Dysfunction Syndrome in Patients with Sepsis
Predicting Death and Multiple Organ Dysfunction Syndrome Using Lactate/Albumin Ratio
Abstract
Introduction: Multiple organ dysfunction syndrome (MODS) is common after sepsis and increases mortality. Lactate (Lac) can assess the prognosis of patients. Albumin (Alb) is closely associated with inflammatory response in sepsis patients. This work evaluated the predictive value of Lac/Alb for prognosis of sepsis patients. Materials and Methods: data of 160 sepsis patients were retrospectively collected. Lac and Alb levels were measured upon admission, at 24 hours and 48 hours later. Using 0.45 as the cutoff value for Lac/Alb, patients were rolled into high-level (HL) and low-level (LL) groups. MODS rates and mortality rates were analyzed. Receiver operating characteristic (ROC) curves were utilized to evaluate the predictive value of 48-hour Lac/Alb for patient prognosis. Correlation between Lac/Alb and APACHE II and SOFA scores was assessed. Results: the 12-month follow-up revealed 52 deaths (32.5%), and MODS occurred in 49 cases (30.6%) on the 7th day. The MODS group possessed elevated Lac and Lac/Alb and decreased Alb to the N-MODS group (P<0.05), and similar results were observed by comparison the survival and death group (P<0.05). The sensitivity, specificity, and area under the ROC curve (AUC) of Lac/Alb in predicting MODS were 81.63%, 85.59%, and 0.89, respectively, while those in predicting death were 94.23%, 88.89%, and 0.91, respectively. Lac/Alb was positively correlated with APACHE II and SOFA scores (r=0.718 and 0.808, respectively). Conclusion: Lac/Alb was linked to MODS and mortality in sepsis patients and can be based to predict adverse outcomes.
References
1. Li X, Liao B, Liu RM, Zhou TT, Zhang N, Zhou J. USP10: A Promising Catalyst for Combating Sepsis-Induced Intestinal Injury via PLK1 Deubiquitination and Stabilization. J Biol Regul Homeost.Agents, 2023;37(5):2703-2711.
2. Sha Y, Wang J, Wang Z, Zhang XS, Chen J. Analysis of the Effect of a New Type of Nano-drug Carrier Preparation on the Pathological Changes in Lung and Inducible Nitric-Oxide Synthase Expression in Severe Sepsis. Cell Mol Biol (Noisy-le-grand), 2022;68(8):1-7.
3. Zou RJ, Tao J, Qiu JX, Lu HM, Wu JH, Zhu H, Li RB, Mui D, Toan S, Chang X, Zhou H, Fan XP. DNA-PKcs promotes sepsis-induced multiple organ failure by triggering mitochondrial dysfunction. J Adv Res, 2022;41:39-48.
4. Deng C, Zhao L, Yang Z, Shang JJ, Wang CY, Shen MZ, Jiang S, Li T, Di WC, Chen Y, Li H, Cheng YD, Yang Y. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. Acta Pharmacol Sin, 2022;43(3):520-528.
5. Pohanka M. D-Lactic Acid as a Metabolite: Toxicology, Diagnosis, and Detection. Biomed Res Int, 2020;2020:3419034(1-9).
6. Goyal P, Agarwal R, Srivastava H, Kar R, Sikka M, Mohta M. Serial Serum Lactic Acid in Pregnancy-Associated Sepsis for Maternal Outcome. J Obstet Gynaecol India, 2020;70(5):342-348.
7. Bihari S, Bannard-Smith J, Bellomo R. Albumin as a drug: its biological effects beyond volume expansion. Crit Care Resusc,. 2020;22(3):257-265.
8. Omiya K, Sato H, Sato T, Wykes L, Hong MY, Hatzakorzian R, Kristof AS, Schricker T. Albumin and fibrinogen kinetics in sepsis: a prospective observational study. Crit Care, 2021;25(1):436(1-6).
9. Basile-Filho A, Lago AF, Menegueti MG, Nicolini EA, Rodrigues LAD, Nunes RS, Auxiliadora-Martins M, Ferez MA. The use of APACHE II, SOFA, SAPS 3, C-reactive protein/albumin ratio, and lactate to predict mortality of surgical critically ill patients: A retrospective cohort study. Medicine (Baltimore), 2019;98(26):e16204(1-7).
10. Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374(1-9).
11. Grondman I, Pirvu A, Riza A, Ioana M, Netea MG. Biomarkers of inflammation and the etiology of sepsis. Biochem Soc Trans, 2020;48(1):1-14.
12. Mei B, Li J, Zuo Z. Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor. Brain Behav Immun, 2021;91:296-314.
13. Joffre J, Hellman J. Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation. Antioxid Redox Signal, 2021;35(15):1291-1307.
14. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Møller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med, 2020;21(2):e52-e106.
15. Caraballo C, Jaimes F. Organ Dysfunction in Sepsis: An Ominous Trajectory From Infection To Death. Yale J Biol Med, 2019;92(4):629-640.
16. Gourd NM, Nikitas N. Multiple Organ Dysfunction Syndrome. J Intensive Care Med, 2020;35(12):1564-1575.
17. Gao L, Xu QH, Ma LN, Luo J, Muyayalo KP, Wang LL, Huang DH, Xiao XJ, Cheng SB, Mor G, Liao AH. Trophoblast-derived Lactic Acid Orchestrates Decidual Macrophage Differentiation via SRC/LDHA Signaling in Early Pregnancy. Int J Biol Sci, 2022;18(2):599-616.
18. Chen XA, Zhou XJ, Zhao H, Wang YX, Pan H, Ma K, Xia ZJ. Clinical Value of the Lactate/Albumin Ratio and Lactate/Albumin Ratio × Age Score in the Assessment of Prognosis in Patients With Sepsis. Front Med (Lausanne), 2021;8:732410(1-9).
19. Xiong W, Zhang L, She K, Xu G, Bai Sl, Liu X. Comparison of machine learning and Logistic regression model in predicting acute kidney injury after cardiac surgery: data analysis based on MIMIC-III database. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2022;34(11):1188-1193.
20. Li W, Wang MP, Zhu B, Zhu YB, Xi XM. Prediction of median survival time in sepsis patients by the SOFA score combined with different predictors. Burns Trauma, 2020;8:tkz006(1-10).
21. Wang Y, Zhang H, Tang XJ, Li XJ. A retrospective study on risk factors for prognosis of children with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2020;32(6):707-710.
22. Zhao CL, Li YY, Wang QY, Yu GW, Hu P, Zhang L, Liu MR, Yuan HY, You PC .Establishment of risk prediction nomograph model for sepsis related acute respiratory distress syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2023;35(7):714-718.
23. China L, Freemantle N, Forrest E, Kallis Y, Ryder SD, Wright G, Portal AJ, Becares Salles N, Gilroy DW, O'Brien A, ATTIRE Trial Investigators. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. N Engl J Med, 2021;384(9):808-817.
24. Wiedermann CJ. Hypoalbuminemia as Surrogate and Culprit of Infections. Int J Mol Sci, 2021;22(9):4496(1-25).
25. Wang ZC, Zhang LM, Li SJ, Xu FS, Han DD, Wang H, Huang T, Yin HY, Lyu J. The relationship between hematocrit and serum albumin levels difference and mortality in elderly sepsis patients in intensive care units-a retrospective study based on two large database. BMC Infect Dis, 2022;22(1):629(1-11).
26. Cortegiani A, Grasselli G, Meessen J, Moscarelli A, Ippolito M, Turvani F, Bonenti CM, Romagnoli S, Volta CA, Bellani G, Giarratano A, Latini R, Pesenti A, Caironi P. Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trial. J Crit Care, 2021;63:83-91.
27. Cakir E, Turan IO. Lactate/albumin ratio is more effective than lactate or albumin alone in predicting clinical outcomes in intensive care patients with sepsis. Scand J Clin Lab Invest, 2021;81(3):225-229.
28. Li FX, Ye ZQ, Zhu JQ, Gu SM, Peng SQ, Fang YL, Hu LH, Xiong JQ. Early Lactate/Albumin and Procalcitonin/Albumin Ratios as Predictors of 28-Day Mortality in ICU-Admitted Sepsis Patients: A Retrospective Cohort Study. Med Sci Monitor, 2023;29:e940654(1-16).
29. Yoon SH, Choi B, Eun S, Bae GE, Koo CM, Kim MK. Using the lactate-to-albumin ratio to predict mortality in patients with sepsis or septic shock: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci, 2022;26(5):1743-1752.
30. Shin J, Hwang SY, Jo IJ, Kim WY, Ryoo SM, Kang GH, Kim K, Jo YH, Chung SP, Joo YS, Beom JH, Yoon YH, Han KS, Lim TH, Choi HS, Kwon WY, Suh GJ, Choi SH, Shin TG. Korean Shock Society (KoSS) Investigators. Prognostic Value of The Lactate/Albumin Ratio for Predicting 28-Day Mortality in Critically ILL Sepsis Patients. Shock, 2018;50(5):545-550.
31. Gao XX, Zhang RJ, Lei ZL, Guo X, Yang YN, Tian J, Huang L. Efficacy, safety, and pharmacoeconomics of sivelestat sodium in the treatment of septic acute respiratory distress syndrome: a retrospective cohort study. Ann Palliat Med, 2021;10(11):11910-11917.
32. Golden GJ, Toledo AG, Marki A, Sorrentino JT, Morris C, Riley RJ, Spliid C, Chen QY, Cornax I, Lewis NE, Varki N, Le D, Malmström J, Karlsson C, Ley K, Nizet V, Esko JD. Endothelial Heparan Sulfate Mediates Hepatic Neutrophil Trafficking and Injury during Staphylococcus aureus Sepsis. mBio, 2021;12(5):e01181-21(1-14).
33. Araste F, Abnous K, Hashemi M, Dehshahri A, Detampel P, Alibolandi M, Ramezani M. Na+/K+ATPase-targeted delivery to metastatic breast cancer models. Eur J Pharm Sci, 2020;143:105207(1-10).
34. Hu J, Liu L, Zeng XH, Wang K, Wang H, Zeng ZJ, Cao YF, Gao LJ, Cheng MX, Wang T, Wen FQ. Prognostic Value of Angiopoietin-like 4 in Patients with Acute Respiratory Distress Syndrome. Shock, 2021;56(3):403-411.
35. Morkar DN, Dwivedi M, Patil P. Comparative study of sofa, apache ii, saps ii, as a predictor of mortality in patients of sepsis admitted in medical ICU. J Assoc Physicians India, 2022;70(4):11-12.
36. Wang B, Chen G, Cao Y, Xue J, Li J, Wu Y. Correlation of lactate/albumin ratio level to organ failure and mortality in severe sepsis and septic shock. J Criti Care, 2015; 30(2): 271-275.
Copyright (c) 2024 Shuwei Huang
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.